On ECHEMI
Home > Drugs > sarcoma
sarcoma
Malignant tumors originating from mesenchymal tissue (including connective tissue and muscle) are called "sarcomas". They often occur in the skin, subcutaneous tissue, periosteum and both ends of long bones. For example, fibrosarcoma grows rapidly, and in the late stage of the tumor, there is often necrosis and bleeding. The cross-section is gray-red and the texture is uniform and fine like raw fish meat. Osteosarcoma is more common in young people and is prone to occur at the ends of the long bones of the limbs, especially the lower end of the femur, the upper end of the tibia and the upper end of the humerus. Osteosarcoma develops rapidly and has a short course of disease. It starts to grow in the cortex and can gradually develop into the bone marrow cavity. Sometimes it breaks through the periosteum and invades the surrounding soft tissue, which can easily cause pathological fractures. Other common ones include leiomyoma, lymphosarcoma, synovial sarcoma, etc. Hematogenous metastasis can occur in the early stage. Sarcoma is a malignant tumor lesion.
  • Site of disease:

    Skin whole body
  • Infectious :

    Not contagious
  • Frequent population:

    How common is it in adults
  • Related symptoms:

    Low fever Low fever fatigue Joint pain Limb pain Nodules
  • Concurrent disease:

Related Drugs
Methotrexate for injection
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia; malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides, multiple myelopathy. 2. Malignant hydatidiform mole, choriocarcinoma, breast cancer, ovarian cancer, cervical cancer, testicular cancer. 3. Head and neck cancer, bronchial lung cancer, various soft tissue sarcomas. 4. High doses are used for osteosarcoma, intrathecal injection can be used to prevent and treat meningeal leukemia and nerve invasion of malignant lymphoma, this product also has a certain effect on psoriasis.
Manufacturer:

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Methotrexate for injection
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia; malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides, multiple myelopathy. 2. Malignant hydatidiform mole, choriocarcinoma, breast cancer, ovarian cancer, cervical cancer, testicular cancer. 3. Head and neck cancer, bronchial lung cancer, various soft tissue sarcomas. 4. High doses are used for osteosarcoma, intrathecal injection can be used to prevent and treat meningeal leukemia and nerve invasion of malignant lymphoma, this product also has a certain effect on psoriasis.
Manufacturer:

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Methotrexate for injection
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia; malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides, multiple myelopathy. 2. Malignant hydatidiform mole, choriocarcinoma, breast cancer, ovarian cancer, cervical cancer, testicular cancer. 3. Head and neck cancer, bronchial lung cancer, various soft tissue sarcomas. 4. High doses are used for osteosarcoma, intrathecal injection can be used to prevent and treat meningeal leukemia and nerve invasion of malignant lymphoma, this product also has a certain effect on psoriasis.
Methotrexate for injection
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia; malignant lymphoma, non-Hodgkin's lymphoma and mycosis fungoides, multiple myelopathy. 2. Malignant hydatidiform mole, choriocarcinoma, breast cancer, ovarian cancer, cervical cancer, testicular cancer. 3. Head and neck cancer, bronchial lung cancer, various soft tissue sarcomas. 4. High doses are used for osteosarcoma, intrathecal injection can be used to prevent and treat meningeal leukemia and nerve invasion of malignant lymphoma, this product also has a certain effect on psoriasis.
Manufacturer:

Qilu Pharmaceutical Co., Ltd.

Cisplatin Injection
Indication: It is the first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is the first-line treatment for SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is the commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervix, esophagus and urinary system tumors. PVB (DDP, VLB, BLM) can treat most stage IV non-spermatogonia testicular cancers, with a remission rate of 50℅ to 80℅. In addition, this product is a radiotherapy sensitizer. It is currently widely used in foreign countries for local radiotherapy of stage IV inoperable NSCLC, which can improve efficacy and survival.
Cisplatin Injection
Indication: It has a wide anti-tumor spectrum and is clinically used to treat testicular malignant tumors. It has good effects on embryonal tumors and seminoma, and has no cross-resistance with commonly used drugs. It has good effects on ovarian cancer, breast cancer and bladder cancer. It also has certain effects on head and neck cancer, lung cancer, esophageal cancer, malignant melanoma, malignant lymphoma, soft tissue sarcoma and cancerous pleural effusion and ascites. It has good effects when used in combination with other anticancer drugs.
Cisplatin Injection
Indication: This product is a first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is a first-line regimen for the treatment of SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is a commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervix, esophagus and urinary system tumors. "PVB" (DDP, VLB, BLM) can treat most stage IV non-spermatogonia testicular cancers with a remission rate of 50% to 80%. In addition, this product is a radiotherapy sensitizer. It is currently widely used in foreign countries for local radiotherapy of stage IV inoperable NSCLC, which can improve efficacy and survival.
Manufacturer:

Yunnan Biovalley Pharmaceutical Co., Ltd.

Cisplatin Injection
Indication: Used for various sarcomas such as nasopharyngeal carcinoma, ovarian cancer, bladder cancer, testicular cancer, lymphosarcoma, reticular cell sarcoma, etc.
Manufacturer:

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Cisplatin Injection
Indication: Used for various sarcomas such as nasopharyngeal carcinoma, ovarian cancer, bladder cancer, testicular cancer, lymphosarcoma, reticular cell sarcoma, etc.
Dacarbazine for injection
Indication: This product is used to treat malignant melanoma
Manufacturer:

Nanjing Pharmaceutical FACTORY Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.